Date: 2024/10/19 - 19:40
NIH clinical trial results expand treatment options for this disease.
Large NIH-funded study supports previous studies showing potential benefit.
NIH-supported clinical trial is the first positive trial for treatment of hereditary hemorrhagic telangiectasia.
Date: 2024/10/19 - 01:25
NIH-funded study focused on original virus strain, unvaccinated participants during pandemic.
